Concepedia

Activity of single-agent melphalan 220–300 mg/m2 with amifostine cytoprotection and autologous hematopoietic stem cell support in non-Hodgkin and Hodgkin lymphoma

G. L. Phillips, Barry Meisenberg, Donna Reece, Val R. Adams, Ashraf Badros, Janet Brunner, R. G. Fenton, Joanne Filicko, Dolores Grosso, Gregory A. Hale,

Bone Marrow Transplantation · 2004 · 24 citations · 36 references

References

36

Nonparametric Estimation from Incomplete Observations

Edward L. Kaplan, Paul Meier · Journal of the American Statistical Association · 1958 · 39.1K citations

Public Health, Biostatistics, Mathematics +10

World Health Organization Classification of Neoplastic Diseases of the Hematopoietic and Lymphoid Tissues: Report of the Clinical Advisory Committee Meeting—Airlie House, Virginia, November 1997

Nancy L. Harris, Elaine S. Jaffe, J Diébold et al. · Journal of Clinical Oncology · 1999 · 3.3K citations

Medicine, Hematology, Pathology +17

Bone Marrow Transplant

Rosemary Ford, Seth Eisenberg · Nursing Clinics of North America · 1990 · 2.7K citations

High-Dose Therapy and Autologous Bone Marrow Transplantation after Failure of Conventional Chemotherapy in Adults with Intermediate-Grade or High-Grade Non-Hodgkin's Lymphoma

Thierry Philip, Jamés O. Armitage, Gary Spitzer et al. · New England Journal of Medicine · 1987 · 781 citations

Medicine, Hematology, Oncology +17

Comparison of 200 mg/m2 melphalan and 8 Gy total body irradiation plus 140 mg/m2 melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myelome 9502 randomized trial

Philippe Moreau · Blood · 2002 · 566 citations · Full text

Medicine, Hematology, Oncology +17